dr. Irina Lambertz
Show
Sort by
-
The HBP1 tumour suppressor at multiple regulatory cross roads in neuroblastoma
-
ETV5 functionally connect ALK and RET signaling in neuroblastoma
-
HBP1 downregulation through mutant ALK represents a novel mechanism for cooperative MYCN activation in neuroblastoma
-
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment
-
Synergistic combined molecular treatment targeting the HBP1 tumor suppressor gene in neuroblastoma
-
Characterization of ALK driven molecular networks identifies perturbed RET and cholinergic signaling in neuroblastoma
-
Green tea compound EGCG activates HBP1: an ALK downstream suppressor gene in neuroblastoma
-
The HBP1 tumor suppressor is a druggable ALK downregulated gene controlling MYCN activity
-
The HBP1 tumor suppressor is a druggable ALK downregulated gene controlling MYCN activity
-
The need for transparency and good practices in the qPCR literature